Last reviewed · How we verify
NCT02821741
Effects of External Ear Stimulation on Pain Perception and Mood
NA trial testing The Twin Stim Plus, 3rd Edition in Pain in Healthy Participants in 76 participants. Currently enrolling.
30 March 2027
Quick facts
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH) |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 76 |
| Start date | 18 October 2016 |
| Primary completion | 30 March 2027 |
| Estimated completion | 30 March 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- The Twin Stim Plus, 3rd Edition
- Medoc Pathway System
Conditions studied
- Pain in Healthy Participants — all drugs for Pain in Healthy Participants →
Sponsor
National Center for Complementary and Integrative Health (NCCIH) — full company profile →
Who can join
Adults 18 to 50, any sex, with Pain in Healthy Participants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The vagus nerve runs from the brain to many organs. Stimulating it can affect the experience of pain. The nerve can be stimulated on the surface of the left ear. Researchers want to study how this stimulation affects the perception of pain. They also want to study how mood affects the experience of pain. Objective: To study the effects of mood and vagus nerve stimulation on the experience of pain. Eligibility: Healthy people ages 18 and older who are fluent in English Design: Participants will be pre-screened with a 15-minute phone call. Participants will have three 2-hour visits. At the screening visit, participants will be screened with: Medical and psychiatric history Physical and psychological exams Questionnaires about physical and psychiatric health and mood Urine tests A heat probe on the forearm. The temperature will be increased until it is painful but tolerable. Participants will have 2 testing sessions within 7 days. Before the testing, they cannot do the following: Eat, use nicotine, or exercise for at least 2 hours Drink alcohol for 24 hours Take certain medicines for 3 days Testing includes: Urine drug screening Left ear stimulation: In one session, the vagus nerve will be stimulated. In the other, an area of the ear away from the vagus nerve will be stimulated. This will be done with mild electric shocks that cause a tingling, pricking, or itchy feeling. Heat applied to the forearm until it is painful but tolerable Completing several forms on a computer or on paper about how they are feeling Monitors on the chest and a finger clip to monitor heart, breathing, and blood pressure
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02821741
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other National Center for Complementary and Integrative Health (NCCIH) trials
Trials by the same sponsor.
- NCT07504601 — Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers · Phase 2 · not yet recruiting
- NCT06052631 — Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused · recruiting
- NCT03952624 — Patient-Centered Assessment of Symptoms and Outcomes · recruiting
- NCT03937778 — Sensory Afferents for Deep Pressure Sensation · NA · completed
- NCT03258580 — Sociocultural & Biobehavioral Influences on Pain Expression and Assessment · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02821741 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Center for Complementary and Integrative Health (NCCIH)
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02821741.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing